| Date | Title | Description |
| 11.02.2026 | GenFlux: $4.2 Million Seed Funding Raised For AI Answer Visibility Platform | GenFlux, a platform that helps brands track and optimize their presence in AI-generated answers, has raised a $4.2 million seed round led by Symbolic Capital, with participation from Borderless Capital, Frachtis, Glasswing Ventures, Dispers... |
| 15.10.2025 | Edge Intelligence Pioneer 375ai Secures $10 Million to Power Next-Gen AI | 375ai secured $10M to advance its edge data intelligence network. The firm transforms raw physical world data into real-time, actionable insights for AI, cities, and enterprises. Its 375edge devices process immense urban information locally... |
| 11.10.2025 | 375ai: $10 Million Raised For Edge Data Intelligence Platform | 375ai, a pioneering edge data intelligence company that converts physical world data into machine-readable insights, has raised an additional $5 million in funding. This recent investment aims to expand its edge data intelligence network, f... |
| 10.10.2025 | 375ai Raises $10M in Funding | 375ai, a Los Angeles, CA-based edge data intelligence company, raised $10M in funding.
The round was led by Delphi Ventures, Strobe Capital and HackVC.
The company intends to use the funds to expand its edge data intelligence network and ad... |
| 13.09.2025 | Sophont: $9.22 Million Seed Funding Secured For Multimodal Medical AI | Sophont, a startup building foundation models that reason across pathology slides, brain scans, clinical notes, and lab results, has closed a $9.22 million seed financing. The round was led by Kindred Ventures with participation from Upfron... |
| 10.11.2022 | APWine raises $2.6 million as it builds a modular interest market in DeFi | Parisian startup APWine has raised $2.6 million in a seed extension round that will see further development of its yield derivative products as well as an expansion of the team size.
The brainchild of a team of engineers from the Swiss Inst... |
| 16.04.2014 | ForSight VISION5 Completes $15M Series C Financing | ForSight VISION5, a Menlo Park, CA-based developer of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy, completed a $15m Series C finan... |
| 10.10.2013 | No catheter, no cuff: FDA clears Sotera Wireless’ continuous noninvasive blood pressure technology | The ViSi Mobile System, a wrist-worn monitor that measures vital signs and is designed to be used in ambulatory, non-ICU clinical settings, and was FDA-cleared in 2012. The company also boasts partnerships with Intermountain Health and Refl... |
| 20.05.2013 | Anticancer drug developer Karyopharm raises more than $48M in series B round | Karyopharm’s selective inhibitors of nuclear export will treat advanced hematologic and solid tumors.
The financing round included Delphi Ventures, which will get a seat on Karyopharm’s board in return for its investment. Deepa R. Pakianath... |
| 23.07.2012 | Late-stage cystic fibrosis, muscular dystrophy drug raises $30 million | With cystic fibrosis the goal is to improve lung function and reduce pulmonary exacerbation. In a Phase 3 clinical study, Ataluren demonstrated trends in improvement in lung function when compared to a placebo. There were also trends in imp... |
| 21.06.2012 | Do Patents Really Matter To Startups? New Data Reveals Shifting Habits | Editor’s note: Leonid Kravets is a patent attorney specializing in developing IP strategy for young technology companies. He blogs on the topic at startupsip.com. Robert J. Moore is the CEO and co-founder of RJMetrics, which helps online bu... |
| 08.11.2011 | Pivot Medical Raises $32M in Series C Financing | Pivot Medical, a Sunnyvale, CA-based medical device company focused on developing and marketing technologies for the hip arthroscopy segment of the orthopedic marketplace, has raised $32m in Series C financing.
The round was led by new inve... |
| 30.06.2011 | AEGEA Medical Closes $13.3M Venture Capital Financing | AEGEA Medical Inc., a Redwood City, Ca.-based developer of a novel, minimally invasive treatment for abnormal uterine bleeding, has completed a $13.3m venture capital financing.
The round was led by Covidien Ventures, with participation fro... |
| 25.03.2010 | Anulex raises $3.8M for spinal surgery device | The first-generation iteration of the Xclose was cleared for U.S. use in general and orthopedic surgery in 2006. The device has been used in more than 7,300 procedures, according to the company.
The most recent cash infusion brings Anulex’s... |
| 25.03.2010 | Anulex Technologies pulls in $4 million | By Brandon Glenn
Fresh from the launch of its next-generation spinal tissue repair device, Anulex Technologies Inc. raised $3.8 million iun a debt and options sale to 11 investors, according to a regulatory filing.
Last month, Anulex began ... |
| 15.06.2009 | Anulex Technologies raises $10.2 million in fourth funding round | Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| 11.03.2009 | Heart drug co. Relypsa gets $10M more to complete trials | Pharmaceutical company Relypsa announced that its investors extended its first round of funding by $10 million to a total $43 million to help it finish phase-two clinical trials on its lead drug candidate, a treatment that could alleviate s... |
| 08.12.2008 | Med device maker Acclarent’s IPO flatlines — but could be revived | Acclarent, maker of medical devices to treat ear, nose and throat conditions, has become the latest biotech firm to withdraw its IPO due to poor market conditions. It originally filed in June, hoping to bring in $86.3 million to expand mark... |
| 24.10.2008 | Phenomix cancels IPO, finds new lab partner | Biopharmaceuticals company Phenomix withdrew its filing to go public yesterday and right away announced a $340-million collaboration deal with Forest Laboratories. The IPO, intended to raise $86.3 million, had been pending since January.
Fo... |
| 14.10.2008 | Migraine sufferers look elsewhere as Cierra buckles | The headache is over for medical device maker Cierra. Actually it’s all over. The Redwood City, Calif.-based company is out of business after failing to draft enough participants into a clinical trial of a catheter-based technology purporte... |
| 09.09.2008 | Proteolix raises $79M for cancer treatment | Proteolix, which is developing drugs to treat cancer by disrupting key cell functions, has raised $79 million in a third round of funding, according to VentureWire. That’s the third largest biotech funding this year.
Nomura Phase4 Ventures,... |
| 30.07.2008 | EBR Systems gets $35 million for new style pacemaker | EBR Systems, which develops cardiac pacing devices, has raised a $35 million third round of financing. This money will help it take its product to clinical trials, according to VentureWire.
Delphi Ventures led this round, with existing inve... |
| 10.07.2007 | FDA clears new uses for Aragon Surgical’s laparascopic device | Aragon Surgical, a Palo Alto, Calif., medical-devices maker, said the FDA cleared its LapCap product for use in general surgery. Aragon, which doesn’t seem to have a Web site, gained ownership of the LapCap when it acquired VeriSure, anothe... |
| 29.06.2007 | Paracor raises $44M for heart-failure device that restrains the heart | (UPDATED: See below.) Paracor Medical, a Sunnyvale, Calif., startup developing a mesh restraint designed to support failing hearts, raised $44.35 million in a fourth round of funding. The company is vying with another device startup, Acorn ... |
| 11.05.2007 | NeuroVista raises $33.8M for epilepsy devices | (CORRECTED: See below.)
Seattle-based NeuroVista, a developer of devices for the treatment of epilepsy, raised $33.8 million in a second-round funding and left behind its former name, BioNeuronics.
The company, founded in 2002 by whiz kid D... |
| - | Senseonics raised $20 million to advance continuous glucose monitoring implant | There are just a handful of big medical device companies that dominate the continuous glucose monitoring space and Senseonics is looking to compete with them. It has raised $20 million across two tranches from current investors to advance a... |
| - | Anulex raises $3.8M for spinal surgery device | Fresh off the launch of a next-generation version of its spinal-tissue repair device, Anulex Technologies has raised $3.8 million, according to a Securities and Exchange Commission filing.
The funding comes in the form of debt and options, ... |
| - | Anticancer drug developer Karyopharm raises more than $48M in series B round | Biotechnology company Karyopharm Therapeutics has raised $48.2 million in a series B round for an innovative group of molecules to combat cancer, according to a company statement.
Karyopharm’s approach, in phase 1 development, targets a gro... |
| - | No catheter, no cuff: FDA clears Sotera Wireless’ continuous noninvasive blood pressure technology | No more catheter, no more cuff for monitoring patient vital signs? Sotera Wireless announced the FDA has given 510(k) clearance to its continuous non-invasive blood pressure (cNIBP) technology, a new feature of its ViSi Mobile patient monit... |
| - | Late-stage cystic fibrosis, muscular dystrophy drug raises $30 million | A biopharmaceutical company with a cystic fibrosis drug in late-stage development has raised $30 million, according to a company statement. It was about $10 million less than the original funding target listed in a form D document with the ... |
| - | Anulex Technologies raises $10.2 million in fourth funding round | MINNETONKA, Minnesota — Anulex Technologies, which treats soft spinal tissue and helps speed recovery after herniated disc removal, raised $10.2 million to complete post-market clinical trials, bolster sales efforts in the United States and... |
